Identification of (−)-cis-6-acetyl-4S-(3-chloro-4-fluoro-benzoylamino)-3,4-dihydro-2,2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent
- 1 January 1999
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (2) , 285-290
- https://doi.org/10.1016/s0960-894x(98)00728-8
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Recent advances in mechanisms of spreading depressionCurrent Opinion in Neurology, 1998
- Characterization of the binding of [3 H]-SB-204269, a radiolabelled form of the new anticonvulsant SB-204269, to a novel binding site in rat brain membranesBritish Journal of Pharmacology, 1997
- Profile of SB‐204269, a mechanistically novel anticonvulsant drug, in rat models of focal and generalized epileptic seizuresBritish Journal of Pharmacology, 1997
- Migraine TreatmentSeminars in Neurology, 1997
- The novel anticonvulsant SB 204269 binds to a stereospecific site in the mouse brainEuropean Journal of Pharmacology, 1996
- Synthesis of Novel trans-4-(Substituted-benzamido)-3,4-dihydro-2H-benzo[b]pyran-3-ol Derivatives as Potential Anticonvulsant Agents with a Distinctive Binding ProfileJournal of Medicinal Chemistry, 1996
- Stereochemical preferences and requirement for the 3-hydroxyl group in novel anticonvulsant 4-fluorobenzoylamino benzopyransBioorganic & Medicinal Chemistry Letters, 1995
- Simultaneous measurement of plasma protein extravasation and carotid vascular resistance in the ratEuropean Journal of Pharmacology, 1995
- Stereochemical differentiation of anticonvulsant and antihypertensive effects in 4-(fluorobenzoylamino)-benzopyransBioorganic & Medicinal Chemistry Letters, 1995